Schonfeld Strategic Advisors LLC Pro Qr Therapeutics N.V. Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 61,900 shares of PRQR stock, worth $233,982. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61,900Holding current value
$233,982% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding PRQR
# of Institutions
53Shares Held
17.3MCall Options Held
26.2KPut Options Held
8.6K-
Privium Fund Management B.V.5.58MShares$21.1 Million2.62% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.63MShares$13.7 Million0.01% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA2.04MShares$7.72 Million0.12% of portfolio
-
M28 Capital Management LP Stamford, CT1.02MShares$3.85 Million1.95% of portfolio
-
Dafna Capital Management LLC Los Angeles, CA906KShares$3.42 Million0.39% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $270M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...